Literature DB >> 28975551

Value-Based Pricing: Do Not Throw Away the Baby with the Bath Water.

Mattias Neyt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 28975551     DOI： 10.1007/s40273-017-0566-5

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

1.  Market spiral pricing of cancer drugs.

Authors:  Donald W Light; Hagop Kantarjian
Journal:  Cancer       Date:  2013-09-03       Impact factor: 6.860

2.  Assessing the value for money of pharmaceuticals in New Zealand--PHARMAC's approach to cost-utility analysis.

Authors:  Rachel Grocott; Scott Metcalfe; Paul Alexander; Rachel Werner
Journal:  N Z Med J       Date:  2013-07-12

3.  Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use.

Authors:  Anthony J Culyer
Journal:  Health Econ Policy Law       Date:  2016-02-24

4.  Publicly funded practice-oriented clinical trials: of importance for healthcare payers.

Authors:  Mattias Neyt; Thierry Christiaens; Jacques Demotes; Tom Walley; Frank Hulstaert
Journal:  J Comp Eff Res       Date:  2016-09-05       Impact factor: 1.744

5.  Why Cancer?

Authors:  Alan Haycox
Journal:  Pharmacoeconomics       Date:  2016-07       Impact factor: 4.981
  5 in total
  2 in total

1.  Value-Based Pricing: L'Enfant Terrible?

Authors:  Sarah Garner; Andrew Rintoul; Suzanne R Hill
Journal:  Pharmacoeconomics       Date:  2018-01       Impact factor: 4.981

2.  Value-based pricing: Toward achieving a balance between individual and population gains in health benefits.

Authors:  Ambica Parmar; Tina Jiao; Ronak Saluja; Kelvin K W Chan
Journal:  Cancer Med       Date:  2019-11-11       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.